496 related articles for article (PubMed ID: 14625258)
1. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
Khokha R
J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
[TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
5. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
6. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells.
Kobayashi T; Okada F; Fujii N; Tomita N; Ito S; Tazawa H; Aoyama T; Choi SK; Shibata T; Fujita H; Hosokawa M
Am J Pathol; 2002 Mar; 160(3):869-82. PubMed ID: 11891186
[TBL] [Abstract][Full Text] [Related]
7. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
[TBL] [Abstract][Full Text] [Related]
8. Thymosin β4: a potential molecular target for tumor therapy.
Xiao Y; Chen Y; Wen J; Yan W; Zhou K; Cai W
Crit Rev Eukaryot Gene Expr; 2012; 22(2):109-16. PubMed ID: 22856429
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
10. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
11. The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells.
Nishisho T; Hata K; Nakanishi M; Morita Y; Sun-Wada GH; Wada Y; Yasui N; Yoneda T
Mol Cancer Res; 2011 Jul; 9(7):845-55. PubMed ID: 21669964
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
Potez M; Trappetti V; Bouchet A; Fernandez-Palomo C; Güç E; Kilarski WW; Hlushchuk R; Laissue J; Djonov V
PLoS One; 2018; 13(11):e0206693. PubMed ID: 30395629
[TBL] [Abstract][Full Text] [Related]
16. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.
Was H; Cichon T; Smolarczyk R; Rudnicka D; Stopa M; Chevalier C; Leger JJ; Lackowska B; Grochot A; Bojkowska K; Ratajska A; Kieda C; Szala S; Dulak J; Jozkowicz A
Am J Pathol; 2006 Dec; 169(6):2181-98. PubMed ID: 17148680
[TBL] [Abstract][Full Text] [Related]
18. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
Yu HR; Schultz RM
Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
20. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
de Aguiar RB; Parise CB; Souza CR; Braggion C; Quintilio W; Moro AM; Navarro Marques FL; Buchpiguel CA; Chammas R; de Moraes JZ
Cancer Lett; 2016 Feb; 371(2):151-60. PubMed ID: 26655277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
